{
    "clinical_study": {
        "@rank": "153000", 
        "acronym": "BHCG", 
        "arm_group": {
            "arm_group_label": "MTX , treatment outcome", 
            "arm_group_type": "Experimental", 
            "description": "patient receiving MTX. in a dosage of 50 mg/m^2 , IM , in single dose"
        }, 
        "brief_summary": {
            "textblock": "The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for\n      Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that \"BHCG\" level\n      in day 10 is the best indicator for treatment success , superior to day 4 and 7 . According\n      to the investigators impression BHCG level rises in days 4 and 7 due to destruction of the\n      trophoblast tissue , and only day 10 is an indicator for treatment success"
        }, 
        "brief_title": "BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ectopic Pregnancy", 
        "condition_browse": {
            "mesh_term": [
                "Pregnancy, Ectopic", 
                "Cardiac Complexes, Premature"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with ectopic pregnancy\n\n          -  healthy\n\n          -  hemodynamic stable\n\n          -  first ectopic\n\n        Exclusion Criteria:\n\n          -  hemodynamic non-stable\n\n          -  abnormal liver or kidney function\n\n          -  allergy reaction to MTX"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860690", 
            "org_study_id": "BHCG1"
        }, 
        "intervention": {
            "arm_group_label": "MTX , treatment outcome", 
            "description": "50 mg / meter squer Intramuscular (IM)  MTX.", 
            "intervention_name": "Methotrexate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Methotrexate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "MTX", 
            "Ectopic pregnancy", 
            "medical treatment"
        ], 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "contact": {
                "email": "kleinz@clalit.org.il", 
                "last_name": "Zvi Klein, MD", 
                "phone": "972-9-7472544"
            }, 
            "facility": {
                "address": {
                    "city": "Kefar-saba", 
                    "country": "Israel"
                }, 
                "name": "Dr. Zvi Klein"
            }, 
            "investigator": {
                "last_name": "Zvi Klein, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success", 
        "overall_contact": {
            "email": "kleinz@clalit.org.il", 
            "last_name": "Zvi Klein, Dr.", 
            "phone": "972-9-7472544"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Clalit Health Services", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To compeer levels of BHCG in days 4 and 7 to day 10 after injection of MTX. for Ectopic pregnancy treatment", 
            "measure": "To measure the change of levels of \"BHCG\" in patients receiving Methotrexate   for treatment of ectopic pregnancy in days 4, 7, and 10 post treatment", 
            "safety_issue": "No", 
            "time_frame": "the change of levels in days 4, 7, and 10 post MTX injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860690"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Meir Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meir Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}